38
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder.

      1 , 1 , 1 , 1 , 1 , 1 , 2 , 3 , 1 , 4
      Cellular and molecular gastroenterology and hepatology
      Elsevier BV
      5-HIAA, 5-hydroxyindoleacetic acid, 5-HT, serotonin, ASD, autism spectrum disorder, FGID, functional gastrointestinal disorder, GI, gastrointestinal, GM-CSF, granulocyte-macrophage colony-stimulating factor, GROα, growth-related oncogene alpha, Gastrointestinal Disorders, IBS, irritable bowel syndrome, IFN, interferon, IL, interleukin, IP, interferon gamma-induced protein, MCP-1, monocyte chemoattractant protein, MIP, macrophage inflammatory protein, Microbiome, Microbiome–Gut–Brain Axis, Mucosa, NT, neurotypical, OTU, operational taxonomic unit, QPGS-RIII, Questionnaire on Pediatric Gastrointestinal Symptoms-Rome III, Serotonin, TNF, tumor necrosis factor, VEGF, vascular endothelial growth factor

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Emerging data on the gut microbiome in autism spectrum disorder (ASD) suggest that altered host-microbe interactions may contribute to disease symptoms. Although gut microbial communities in children with ASD are reported to differ from individuals with neurotypical development, it is not known whether these bacteria induce pathogenic neuroimmune signals.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: found
          • Article: not found

          Pyrosequencing study of fecal microflora of autistic and control children.

          There is evidence of genetic predisposition to autism, but the percent of autistic subjects with this background is unknown. It is clear that other factors, such as environmental influences, may play a role in this disease. In the present study, we have examined the fecal microbial flora of 33 subjects with various severities of autism with gastrointestinal symptoms, 7 siblings not showing autistic symptoms (sibling controls) and eight non-sibling control subjects, using the bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP) procedure. The results provide us with information on the microflora of stools of young children and a compelling picture of unique fecal microflora of children with autism with gastrointestinal symptomatology. Differences based upon maximum observed and maximum predicted operational taxonomic units were statistically significant when comparing autistic and control subjects with p-values ranging from <0.001 to 0.009 using both parametric and non-parametric estimators. At the phylum level, Bacteroidetes and Firmicutes showed the most difference between groups of varying severities of autism. Bacteroidetes was found at high levels in the severely autistic group, while Firmicutes were more predominant in the control group. Smaller, but significant, differences also occurred in the Actinobacterium and Proteobacterium phyla. Desulfovibrio species and Bacteroides vulgatus are present in significantly higher numbers in stools of severely autistic children than in controls. If the unique microbial flora is found to be a causative or consequent factor in this type of autism, it may have implications with regard to a specific diagnostic test, its epidemiology, and for treatment and prevention. Copyright (c) 2010 Elsevier Ltd. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

            The mechanisms underlying abdominal pain perception in irritable bowel syndrome (IBS) are poorly understood. Intestinal mast cell infiltration may perturb nerve function leading to symptom perception. We assessed colonic mast cell infiltration, mediator release, and spatial interactions with mucosal innervation and their correlation with abdominal pain in IBS patients. IBS patients were diagnosed according to Rome II criteria and abdominal pain quantified according to a validated questionnaire. Colonic mucosal mast cells were identified immunohistochemically and quantified with a computer-assisted counting method. Mast cell tryptase and histamine release were analyzed immunoenzymatically. Intestinal nerve to mast cell distance was assessed with electron microscopy. Thirty-four out of 44 IBS patients (77%) showed an increased area of mucosa occupied by mast cells as compared with controls (9.2% +/- 2.5% vs. 3.3 +/- 0.8%, respectively; P < 0.001). There was a 150% increase in the number of degranulating mast cells (4.76 +/- 3.18/field vs. 2.42 +/- 2.26/field, respectively; P = 0.026). Mucosal content of tryptase was increased in IBS and mast cells spontaneously released more tryptase (3.22 +/- 3.48 pmol/min/mg vs. 0.87 +/- 0.65 pmol/min/mg, respectively; P = 0.015) and histamine (339.7 +/- 59.0 ng/g vs. 169.3 +/- 130.6 ng/g, respectively; P = 0.015). Mast cells located within 5 microm of nerve fibers were 7.14 +/- 3.87/field vs. 2.27 +/- 1.63/field in IBS vs. controls (P < 0.001). Only mast cells in close proximity to nerves were significantly correlated with severity and frequency of abdominal pain/discomfort (P < 0.001 and P = 0.003, respectively). Colonic mast cell infiltration and mediator release in proximity to mucosal innervation may contribute to abdominal pain perception in IBS patients.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Elevated immune response in the brain of autistic patients.

              This study determined immune activities in the brain of ASD patients and matched normal subjects by examining cytokines in the brain tissue. Our results showed that proinflammatory cytokines (TNF-alpha, IL-6 and GM-CSF), Th1 cytokine (IFN-gamma) and chemokine (IL-8) were significantly increased in the brains of ASD patients compared with the controls. However the Th2 cytokines (IL-4, IL-5 and IL-10) showed no significant difference. The Th1/Th2 ratio was also significantly increased in ASD patients. ASD patients displayed an increased innate and adaptive immune response through the Th1 pathway, suggesting that localized brain inflammation and autoimmune disorder may be involved in the pathogenesis of ASD.
                Bookmark

                Author and article information

                Journal
                Cell Mol Gastroenterol Hepatol
                Cellular and molecular gastroenterology and hepatology
                Elsevier BV
                2352-345X
                2352-345X
                Mar 2017
                : 3
                : 2
                Affiliations
                [1 ] Texas Children's Microbiome Center, Department of Pathology, Texas Children's Hospital, Houston, Texas; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas.
                [2 ] Department of Psychiatry, Columbia University, New York, New York.
                [3 ] Yale Child Study Center, Yale University School of Medicine, New Haven, Connecticut; Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut.
                [4 ] Department of Pediatric Gastroenterology, Hepatology, and Nutrition, Nationwide Children's Hospital, Columbus, Ohio.
                Article
                S2352-345X(16)30136-9
                10.1016/j.jcmgh.2016.11.008
                5331780
                28275689
                bfec8be7-f757-48d5-a289-e685728d390f
                History

                5-HIAA, 5-hydroxyindoleacetic acid,5-HT, serotonin,ASD, autism spectrum disorder,FGID, functional gastrointestinal disorder,GI, gastrointestinal,GM-CSF, granulocyte-macrophage colony-stimulating factor,GROα, growth-related oncogene alpha,Gastrointestinal Disorders,IBS, irritable bowel syndrome,IFN, interferon,IL, interleukin,IP, interferon gamma-induced protein,MCP-1, monocyte chemoattractant protein,MIP, macrophage inflammatory protein,Microbiome,Microbiome–Gut–Brain Axis,Mucosa,NT, neurotypical,OTU, operational taxonomic unit,QPGS-RIII, Questionnaire on Pediatric Gastrointestinal Symptoms-Rome III,Serotonin,TNF, tumor necrosis factor,VEGF, vascular endothelial growth factor

                Comments

                Comment on this article